28 related articles for article (PubMed ID: 33166687)
1. Design, Synthesis, and Biological Evaluation of Novel Quinazoline Derivatives Possessing a Trifluoromethyl Moiety as Potential Antitumor Agents.
Chen M; Cheng S; Dai X; Yu J; Wang H; Xu B; Luo H; Xu G
Chem Biodivers; 2024 May; 21(5):e202301776. PubMed ID: 38602834
[TBL] [Abstract][Full Text] [Related]
2. Lipid-conjugated Smac analogues.
Micewicz ED; Ratikan JA; Waring AJ; Whitelegge JP; McBride WH; Ruchala P
Bioorg Med Chem Lett; 2015 Oct; 25(20):4419-27. PubMed ID: 26384289
[TBL] [Abstract][Full Text] [Related]
3. Design, in silico evaluation, and in vitro verification of new bivalent Smac mimetics with pro-apoptotic activity.
Huang Q; Peng Y; Peng Y; Lin H; Deng S; Feng S; Wei Y
Methods; 2024 Apr; 224():35-46. PubMed ID: 38373678
[TBL] [Abstract][Full Text] [Related]
4. Design of Evodiamine-Glucose Conjugates with Improved
Wu Z; Chen S; Chen Z; Dong G; Xu D; Sheng C
J Med Chem; 2024 May; 67(9):7373-7384. PubMed ID: 38646851
[TBL] [Abstract][Full Text] [Related]
5. In Vitro Inhibition of Hsp90 Protein by Benzothiazoloquinazolinequinones Is Enhanced in The Presence of Ascorbate. A Preliminary In Vivo Antiproliferative Study.
Valderrama JA; Ríos D; Muccioli GG; Buc Calderon P; Benites J
Molecules; 2020 Feb; 25(4):. PubMed ID: 32093392
[TBL] [Abstract][Full Text] [Related]
6. Quinazolines annelated at the N(3)-C(4) bond: Synthesis and biological activity.
Nosova EV; Lipunova GN; Permyakova YV; Charushin VN
Eur J Med Chem; 2024 May; 271():116411. PubMed ID: 38669910
[TBL] [Abstract][Full Text] [Related]
7. IAP Proteins Antagonist: An Introduction and Chemistry of Smac Mimetics under Clinical Development.
Ali R; Singh S; Haq W
Curr Med Chem; 2018; 25(31):3768-3795. PubMed ID: 29532750
[TBL] [Abstract][Full Text] [Related]
8. Bivalent SMAC Mimetics for Treating Cancer by Antagonizing Inhibitor of Apoptosis Proteins.
Zhu H; Li Y; Liu Y; Han B
ChemMedChem; 2019 Dec; 14(23):1951-1962. PubMed ID: 31692274
[TBL] [Abstract][Full Text] [Related]
9. Discovery of a novel class of dimeric Smac mimetics as potent IAP antagonists resulting in a clinical candidate for the treatment of cancer (AZD5582).
Hennessy EJ; Adam A; Aquila BM; Castriotta LM; Cook D; Hattersley M; Hird AW; Huntington C; Kamhi VM; Laing NM; Li D; MacIntyre T; Omer CA; Oza V; Patterson T; Repik G; Rooney MT; Saeh JC; Sha L; Vasbinder MM; Wang H; Whitston D
J Med Chem; 2013 Dec; 56(24):9897-919. PubMed ID: 24320998
[TBL] [Abstract][Full Text] [Related]
10. Discovery of potent heterodimeric antagonists of inhibitor of apoptosis proteins (IAPs) with sustained antitumor activity.
Perez HL; Chaudhry C; Emanuel SL; Fanslau C; Fargnoli J; Gan J; Kim KS; Lei M; Naglich JG; Traeger SC; Vuppugalla R; Wei DD; Vite GD; Talbott RL; Borzilleri RM
J Med Chem; 2015 Feb; 58(3):1556-62. PubMed ID: 25584393
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biological evaluation of some novel substituted quinazolines as antitumor agents.
Alanazi AM; Abdel-Aziz AA; Al-Suwaidan IA; Abdel-Hamide SG; Shawer TZ; El-Azab AS
Eur J Med Chem; 2014 May; 79():446-54. PubMed ID: 24763265
[TBL] [Abstract][Full Text] [Related]
12. Potent bivalent Smac mimetics: effect of the linker on binding to inhibitor of apoptosis proteins (IAPs) and anticancer activity.
Sun H; Liu L; Lu J; Bai L; Li X; Nikolovska-Coleska Z; McEachern D; Yang CY; Qiu S; Yi H; Sun D; Wang S
J Med Chem; 2011 May; 54(9):3306-18. PubMed ID: 21462933
[TBL] [Abstract][Full Text] [Related]
13. Discovery of quinazoline derivatives as a novel class of potent and in vivo efficacious LSD1 inhibitors by drug repurposing.
Li Z; Qin T; Li Z; Zhao X; Zhang X; Zhao T; Yang N; Miao J; Ma J; Zhang Z
Eur J Med Chem; 2021 Dec; 225():113778. PubMed ID: 34416665
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of new bivalent quinazoline analogues as IAP antagonists.
Bae I; Kim D; Choi J; Kim J; Kim M; Park B; Kim YH; Ahn YG; Hyung Kim H; Kim DK
Bioorg Med Chem Lett; 2021 Feb; 34():127676. PubMed ID: 33166687
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
